Skip to main content
SpringerLink
Log in

Inadequate warning of sodium valproate-related birth defects

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dyer C. Sodium valproate: Sanofi is indicted in France for failing to warn adequately about birth defects. BMJ 2020: m539, No. 368, 7 Feb 2020. Available from: URL: https://doi.org/10.1136/bmj.m539

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inadequate warning of sodium valproate-related birth defects. Reactions Weekly 1791, 6 (2020). https://doi.org/10.1007/s40278-020-74851-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74851-5

Search

Navigation